Find Tucidinostat manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Epidaza, 1616493-44-7, Hbi-8000, Cs-055, Cs055, 743438-44-0
Molecular Formula
C22H19FN4O2
Molecular Weight
390.4  g/mol
InChI Key
SZMJVTADHFNAIS-BJMVGYQFSA-N
FDA UNII
87CIC980Y0

Tucidinostat
Tucidinostat is an orally bioavailable benzamide-type inhibitor of histone deacetylase (HDAC) isoenzymes 1, 2, 3 and 10, with potential antineoplastic activity. Upon administration, tucidinostat binds to and inhibits HDACs, leading to an increase of acetylation levels of histone proteins. This agent also inhibits the expression of kinases in the PI3K/Akt and MAPK/Ras signaling pathways and may result in cell cycle arrest and the induction of tumor cell apoptosis. This may inhibit tumor cell proliferation in susceptible tumor cells. HDACs, a class of enzymes that deacetylate chromatin histone proteins, are upregulated in many tumor types and play key roles in gene expression. Compared to some other benzamide-type HDAC inhibitors, chidamide is more stable, more resistant to degradation and has a longer half-life.
1 2D Structure

Tucidinostat

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-(2-amino-4-fluorophenyl)-4-[[[(E)-3-pyridin-3-ylprop-2-enoyl]amino]methyl]benzamide
2.1.2 InChI
InChI=1S/C22H19FN4O2/c23-18-8-9-20(19(24)12-18)27-22(29)17-6-3-16(4-7-17)14-26-21(28)10-5-15-2-1-11-25-13-15/h1-13H,14,24H2,(H,26,28)(H,27,29)/b10-5+
2.1.3 InChI Key
SZMJVTADHFNAIS-BJMVGYQFSA-N
2.1.4 Canonical SMILES
C1=CC(=CN=C1)C=CC(=O)NCC2=CC=C(C=C2)C(=O)NC3=C(C=C(C=C3)F)N
2.1.5 Isomeric SMILES
C1=CC(=CN=C1)/C=C/C(=O)NCC2=CC=C(C=C2)C(=O)NC3=C(C=C(C=C3)F)N
2.2 Other Identifiers
2.2.1 UNII
87CIC980Y0
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (e)-n-(2-amino-4-fluorophenyl)-4-((3-(pyridin-3-yl)acrylamido)methyl)benzamide

2. Hbi-8000

2.3.2 Depositor-Supplied Synonyms

1. Epidaza

2. 1616493-44-7

3. Hbi-8000

4. Cs-055

5. Cs055

6. 743438-44-0

7. (e)-n-(2-amino-4-fluorophenyl)-4-((3-(pyridin-3-yl)acrylamido)methyl)benzamide

8. De-5-fluoro 4-fluorochidamide

9. Tucidinostat [usan]

10. Chidamide [who-dd]

11. 87cic980y0

12. Cs 055

13. N-(2-amino-4-fluorophenyl)-4-[[[(e)-3-pyridin-3-ylprop-2-enoyl]amino]methyl]benzamide

14. N-(2-amino-4-fluorophenyl)-4-(((1-oxo-3-(3-pyridinyl)-2-propen-1-yl)amino)methyl)benzamide

15. Benzamide, N-(2-amino-4-fluorophenyl)-4-((((2e)-1-oxo-3-(3-pyridinyl)-2-propen-1-yl)amino)methyl)-

16. Benzamide, N-(2-amino-4-fluorophenyl)-4-(((1-oxo-3-(3-pyridinyl)-2-propen-1-yl)amino)methyl)-

17. Tucidinostat Hcl

18. Epidaza In China

19. Epidaza (tn)

20. Tucidinostat [inn]

21. Tucidinostat [jan]

22. Tucidinostat [who-dd]

23. Unii-87cic980y0

24. Tucidinostat (jan/usan/inn)

25. Chembl3621988

26. Schembl13815849

27. Chebi:135918

28. Dtxsid701032295

29. Ex-a3245

30. Bdbm50457079

31. Db06334

32. Chidamide; Hbi-8000; Cs-055 Hcl

33. Bs-15501

34. Hy-109015

35. Cs-0030513

36. A51185

37. D10993

38. A899933

39. Q19903814

40. Benzamide, N-(2-amino-4-fluorophenyl)-4-(((1-oxo-3-(3-pyridinyl)-2-propen-1-yl)amino)methyl)-benzamide, N-(2-amino-4-fluorophenyl)-4-((((2e)-1-oxo-3-(3-pyridinyl)-2-propen-1-yl)amino)methyl)-

41. N-(2-amino-4-fluorophenyl)-4-(((2e)-3-(pyridin-3-yl)prop- 2-enamido)methyl)benzamide

42. N-(2-amino-4-fluorophenyl)-4-{(3-(pyridin-3-yl)prop-2-enamido)methyl}benzamide N-(2-amino-4-fluorophenyl)-4-{((2e)-3-(pyridin-3-yl)prop-2-enamido)methyl}benzamide

2.4 Create Date
2007-02-07
3 Chemical and Physical Properties
Molecular Weight 390.4 g/mol
Molecular Formula C22H19FN4O2
XLogP32.3
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count5
Rotatable Bond Count6
Exact Mass390.14920402 g/mol
Monoisotopic Mass390.14920402 g/mol
Topological Polar Surface Area97.1 Ų
Heavy Atom Count29
Formal Charge0
Complexity577
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in cancer/tumors (unspecified).


5 Pharmacology and Biochemistry
5.1 Mechanism of Action

Chidamide is an orally bioavailable histone deacetylase (HDAC) inhibitor derived from the benzamide class. Histone deacetylase inhibitors are a class of cancer drugs that induce selective regulation of gene expression in cancer cells. [HUYA Biosciences Press Release]


Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Tucidinostat Manufacturers

A Tucidinostat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tucidinostat, including repackagers and relabelers. The FDA regulates Tucidinostat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tucidinostat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Tucidinostat Suppliers

A Tucidinostat supplier is an individual or a company that provides Tucidinostat active pharmaceutical ingredient (API) or Tucidinostat finished formulations upon request. The Tucidinostat suppliers may include Tucidinostat API manufacturers, exporters, distributors and traders.

click here to find a list of Tucidinostat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Tucidinostat USDMF

A Tucidinostat DMF (Drug Master File) is a document detailing the whole manufacturing process of Tucidinostat active pharmaceutical ingredient (API) in detail. Different forms of Tucidinostat DMFs exist exist since differing nations have different regulations, such as Tucidinostat USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Tucidinostat DMF submitted to regulatory agencies in the US is known as a USDMF. Tucidinostat USDMF includes data on Tucidinostat's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tucidinostat USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Tucidinostat suppliers with USDMF on PharmaCompass.

Tucidinostat GMP

Tucidinostat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Tucidinostat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tucidinostat GMP manufacturer or Tucidinostat GMP API supplier for your needs.

Tucidinostat CoA

A Tucidinostat CoA (Certificate of Analysis) is a formal document that attests to Tucidinostat's compliance with Tucidinostat specifications and serves as a tool for batch-level quality control.

Tucidinostat CoA mostly includes findings from lab analyses of a specific batch. For each Tucidinostat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Tucidinostat may be tested according to a variety of international standards, such as European Pharmacopoeia (Tucidinostat EP), Tucidinostat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tucidinostat USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty